CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) indication : diabetes mellitus, type 2
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
2019, January 25, 2019
|
Edition: | Final |
Series: | CADTH common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Physical Description: | 1 PDF file (7 pages) |
---|